Overspill of Catheter Locking Solution: Safety and Efficacy Aspects

ASAIO Journal

Volumn 49, Issue 6, 2003, Pages 713-715

  Polaschegg, Hans Dietrich ^b   Shah, Chirag ^a  

^a Biolink Corporation   (United States)

^b NONE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; FLUID DYNAMICS; PATIENT TREATMENT;

ANTICOAGULANT SOLUTION;

CATHETERS;

ANTICOAGULANT AGENT; CATHETER LOCKING SOLUTION; DYE; HEPARIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD ACCESS DEVICE; CATHETER; CATHETER FILLING VOLUME; COMPLIANCE (PHYSICAL); CONCENTRATION (PARAMETERS); DEVICE; DRUG INJECTION VOLUME; FLOW KINETICS; PARTIAL THROMBOPLASTIN TIME; PHENOMENOLOGY; SAFETY; SPILLAGE;

ANTICOAGULANTS; CATHETERIZATION, PERIPHERAL; COLORING AGENTS; HEPARIN; HUMANS; INJECTIONS, INTRAVENOUS; PILOT PROJECTS; SODIUM CHLORIDE;

EID: 0242509905     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MAT.0000094040.54794.2D     Document Type: Article

References (11)

1. National Kidney Foundation: K/DOQI clinical practice guidelines for vascular access, 2000. Am J Kidney Dis 37: S137-S181 (Suppl 1), 2001.
2. Pisoni RL, Young EW, Dykstra DM, et al: Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 61: 305-316, 2002.
3. Karaaslan H, Peyronnet P, Benevent D, et al: Risk of heparin lock-related bleeding when using indwelling venous catheter in haemodialysis. Nephrol Dial Transplant 16: 2072-2074, 2001.
4. Lynn RI: Reduced incidence of hemodialysis (HD) catheter related bacteremia (CRB) using a weekly citrate-gentamicin lock (CGL). J Am Soc Nephrol A1006, 2000.
5. Ash SR, Mankus RA, Sutton JM, et al: Concentrated sodium citrate (23%) for catheter lock. Hemodial Int 4: 22-31, 2000.
6. Levin NW, Yang PM, Hatch DA, et al: New access device for hemodialysis. ASAIO J 44: M529-M531, 1998.
7. Canaud B, Beraud JJ, Joyeux H, Mion C: Internal jugular vein cannulation with two silicone rubber catheters: a new and safe temporary vascular access for hemodialysis. Thirty months' experience. Artif Organs 10: 397-403, 1986.
8. Polaschegg HD, Sodemann K, Estabrook B: Investigation of the effect of catheter side holes on flow properties and outwash of the locking solution, in Proceedings of the 2nd Symposium on Angioaccess for Hemodialysis, Maastricht, The Netherlands: Vascular Access Society, 1999. p. 195.
9. Food and Drug Administration: FDA issues warning on tricitrasol dialysis catheter anticoagulant. FDA Talk Paper T00-16, 14 April 2000.
10. Sodemann K, Polaschegg HD, Feldmer B. Two years' experience with Dialock and CLS TM (a new antimicrobial lock solution). Blood Purif 19: 251-254, 2001.
11. Shah CB, Mittelmann MW, Costerton JW, et al: Antimicrobial activity of a novel catheter locking solution. Antimicrob Agents Chemother 46: 1674-1679, 2002.